D.C. Appeals Court OKs "Authorized Generics"
In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court has ruled that brand-name drug companies have the right to sell unbranded versions of their own drugs...To view the full article, register now.
Already a subscriber? Click here to view full article